Skip to main content
FDA clears OrbusNeich's PTCA balloon dilatation catheters

OrbusNeich has obtained clearance from the FDA to market its Sapphire II PRO and Sapphire NC Plus percutaneous transluminal coronary angioplasty balloon dilatation catheters. The Sapphire NC Plus is intended for post-delivery expansion of balloon expandable coronary stents and in-stent restenosis dilatation, while the Sapphire II Pro enables entry through tight lesions because it comes with an ultra-low profile and a tapered tip.

Full Story: